DE10390251D2 - Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung - Google Patents
Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre VerwendungInfo
- Publication number
- DE10390251D2 DE10390251D2 DE10390251T DE10390251T DE10390251D2 DE 10390251 D2 DE10390251 D2 DE 10390251D2 DE 10390251 T DE10390251 T DE 10390251T DE 10390251 T DE10390251 T DE 10390251T DE 10390251 D2 DE10390251 D2 DE 10390251D2
- Authority
- DE
- Germany
- Prior art keywords
- trojan
- inhibitors
- processes
- production
- trojan inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10390251T DE10390251D2 (de) | 2002-01-27 | 2003-01-27 | Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10204210 | 2002-01-27 | ||
DE10203862 | 2002-01-27 | ||
DE10209064 | 2002-02-28 | ||
PCT/DE2003/000265 WO2003064453A2 (de) | 2002-01-27 | 2003-01-27 | Trojanische inhibitoren, verfahren zu ihrer herstellung und ihre verwendung |
DE10390251T DE10390251D2 (de) | 2002-01-27 | 2003-01-27 | Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10390251D2 true DE10390251D2 (de) | 2004-12-23 |
Family
ID=27669716
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10304202A Withdrawn DE10304202A1 (de) | 2002-01-27 | 2003-01-27 | Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung |
DE10390251T Expired - Fee Related DE10390251D2 (de) | 2002-01-27 | 2003-01-27 | Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10304202A Withdrawn DE10304202A1 (de) | 2002-01-27 | 2003-01-27 | Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003208275A1 (de) |
DE (2) | DE10304202A1 (de) |
WO (1) | WO2003064453A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201863D0 (en) * | 2002-06-18 | 2002-06-18 | Cepep Ab | Cell penetrating peptides |
DE102006008321A1 (de) * | 2006-02-17 | 2007-08-30 | Virologik Gmbh | Mittel zur Behandlung von Infektionen mit Influenzaviren |
WO2012038950A1 (en) | 2010-09-20 | 2012-03-29 | Ramot At Tel-Aviv University Ltd. | Activatable toxin complexes comprising a cleavable inhibitory peptide |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221355B1 (en) * | 1997-12-10 | 2001-04-24 | Washington University | Anti-pathogen system and methods of use thereof |
ES2328796T3 (es) * | 2001-03-14 | 2009-11-18 | Myriad Genetics, Inc. | Interaccion tsg101-gag y uso de la misma. |
US20030138444A1 (en) * | 2001-08-18 | 2003-07-24 | Myriad Genetics, Incorporated | Composition and method for treating HIV infection |
-
2003
- 2003-01-27 DE DE10304202A patent/DE10304202A1/de not_active Withdrawn
- 2003-01-27 WO PCT/DE2003/000265 patent/WO2003064453A2/de not_active Application Discontinuation
- 2003-01-27 AU AU2003208275A patent/AU2003208275A1/en not_active Abandoned
- 2003-01-27 DE DE10390251T patent/DE10390251D2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2003064453A3 (de) | 2004-02-12 |
DE10304202A1 (de) | 2003-12-04 |
AU2003208275A1 (en) | 2003-09-02 |
WO2003064453A2 (de) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10393704D2 (de) | Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung | |
ATE347890T1 (de) | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren | |
ATE348609T1 (de) | Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
DE60313602D1 (de) | N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG | |
DE60334183D1 (de) | Faserplatte und Verfahren zu ihrer Herstellung | |
DE502005007840D1 (de) | 7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE502004011957D1 (de) | Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE50312261D1 (de) | Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE60233058D1 (de) | Silsesquioxanderivate und verfahren zu ihrer herstellung | |
ATE554113T1 (de) | Butencopolymere und verfahren zu ihrer herstellung | |
DE50310782D1 (de) | Piezoaktor und verfahren zu dessen herstellung | |
ATE268756T1 (de) | Substituierte karbazole, verfahren zu ihrer herstellung und ihre verwendung als spla2- inhibitoren | |
DE50207011D1 (de) | Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
ATE473738T1 (de) | 1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden | |
ATE272634T1 (de) | Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung | |
ATE535510T1 (de) | Benzylamine, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmende mittel | |
ATE384069T1 (de) | Alkyliden-tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
DE50307428D1 (de) | Sitzeinlage und verfahren zu ihrer herstellung | |
DE502004005578D1 (de) | Hochtackige klebmasse, verfahren zu deren herstellung und deren verwendung | |
ATE517853T1 (de) | Mörtelzusammensetzung, verfahren zu ihrer herstellung und ihre verwendung | |
DE50306943D1 (de) | Pflanzliche plazenta-extrakte, verfahren zu ihrer herstellung und ihre verwendung | |
DE03743522T1 (de) | Wässrige dispersion, verfahren zu ihrer herstellung und ihre verwendung | |
ATE302765T1 (de) | 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
PT1663997E (pt) | 1h-azolilmetilamidas, processos para a sua produção e a sua utilização como inibidores de nitrificação | |
ATE313556T1 (de) | Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |